News & Insights

Archimedes Named to the Inc. 5000 List of Fastest-growing Companies

August 2023

BRENTWOOD, TN August 15, 2023 – Archimedes, a recognized leader in specialty drug management solutions, has been named to the 2023 Inc. 5000 list of fastest-growing private companies in America – ranking in the top 100 in the Health Services industry.  The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most dynamic segment—independent, entrepreneurial businesses. Facebook, Chobani, Under Armour, Microsoft, Patagonia, and many other household name brands gained their first national exposure as honorees on the Inc. 5000.

“This remarkable achievement signifies that we are reaching a critical mass of employers who are disillusioned by the status quo and looking for a more effective way to manage specialty medications,” said Dr. Brenda Motheral PhD, CEO and Co-Founder of Archimedes. “Our demonstrated results in reducing specialty drug spend has been the key ingredient to our success and driver of our extraordinary growth.”

Archimedes’ specialty drug management programs are delivering reductions in specialty spend ranging from 30-50% in the first year following the program and are providing sustained lower spend over multiple years. At the patient level, Archimedes has delivered savings as much as $1M per patient annually while improving clinical outcomes.

For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, location, and other criteria, click here.


About Archimedes

Archimedes is the industry leader in specialty drug management solutions. Founded with the goal of transforming the PBM industry to provide the necessary ingredients for the sustainability of the prescription drug benefit – alignment, value and transparency – Archimedes achieves superior results for clients by eliminating tightly held PBM conflicts of interest including drug spread, rebate retention and pharmacy ownership and delivering the most rigorous clinical management at the lowest net cost.

For media inquiries contact

Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now